Home Tags Drug Development

Drug Development Related Content

next big pandemic

Antimicrobial resistance: The next big pandemic?

Josep Figueras and Anna Sagan from the European Observatory on Health Systems and Policies focus here on antimicrobial resistance and ponder whether or not this could be the next big pandemic.
Quality of medicinal cannabis, purely plant

Ensuring a high and reproducible quality of medicinal cannabis

Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
COVID-19 and pulmonary fibrosis, EU-IPFF

COVID-19 and pulmonary fibrosis

Steve Jones, President of EU-IPFF and Chair, Action for Pulmonary Fibrosis in the UK describes the connection between COVID-19 and pulmonary fibrosis.
pancreatic cancer patients, new drug

New drug offers promising treatment for pancreatic cancer patients

Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.
New antibiotics

Finding new antibiotics: The genome way

Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.
COVID-19 vaccine, innovation

Cambridge COVID-19 vaccine gets £1.9 million to start trials

The University of Cambridge are developing a COVID-19 vaccine, which is expected to start clinical trials in Autumn 2020.
antibiotic resistance, COVID-19

Nightingale hospitals could increase antibiotic resistance

The University of Plymouth revealed that secondary COVID-19 treatment could be increasing antibiotic resistance and polluting water.
reverse vision loss, eye

New cell injection technique could reverse vision loss

Researchers at the University of Toronto Engineering tried co-injection of both retinal pigmented epithelium (RPE) cells and photoreceptor cells to reverse vision loss.
drug development trial, male bias

Male bias in drug development trials creates overmedication

New research shows that the gender gap in drug development trials results in an overmedication of women by healthcare professionals.
21 drugs, COVID

21 drugs that could help to treat COVID-19

A study recently identified 21 existing drugs that could improve the effect of remdesivir.
natural epidural

Genetic variant acts as a natural epidural, relieving pain in childbirth

Scientists at the University of Cambridge have discovered a genetic variant that acts as a natural epidural, explaining why some women do not need pain relief during childbirth.
blood iron levels, university of edinburgh

Blood iron levels could be the reason behind slow ageing

Scientists from the University of Edinburgh and Max Planck Institute for Biology of Ageing identify blood iron levels as an ageing factor.
lung cancer treatment, nanoparticles

Can nanoparticles change lung cancer treatment?

A promising idea for lung cancer treatment has been developed by researchers at Lund University.
remdesivir covid

New research says remdesivir could be used to treat COVID-19

There is more positive news regarding remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19.
curevac, SARS-CoV-2

EIB provide CureVac with €75m financing to fight infectious diseases

EIB and CureVac have signed a €75m loan agreement to develop a large-scale production of vaccines, including CureVac's vaccine candidate against SARS-CoV-2.
THC in CBD, EUMCA

EUMCA: Limit of 0.2% THC in CBD products should not change

Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.
access to medicinal cannabis, trevor jones

The EUMCA: Pioneering access to medicinal cannabis

Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
biochemistry

How does research in biochemistry fit into the wider goals of the NIH?

Open Access Government looks into the National Institute of General Medical Sciences (NIGMS)’s Biochemistry and Bio-related Chemistry Branch, and its current research areas and priorities.
vision disorders

How can biomaterials-based technologies treat vision disorders?

Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.
cytochromes p450

Cytochromes P450: Chemistry for drugs, metabolism, and beyond

Joseph Najjar and Andrew K. Udit, PhD from the Department of Chemistry at Occidental College enlighten us on the importance of Cytochromes P450 in medicine and industry.

Follow Open Access Government